SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the community discusses potential partnerships and adoption by major players. Chatter revolves around Pyth's role in the Real World Asset (RWA) space, with some speculating on future price targets. Discussions also highlight the potential impact of institutional adoption and expansion into new markets.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community anticipates a potential ETF, with many discussing key price levels and expressing bullish sentiment. Some are pointing to technical indicators suggesting a possible breakout and expressing excitement about potential gains. The broader crypto market trends and potential rate cuts are also fueling optimism.

Ainalyzr is a versatile and engaging platform designed to provide crypto traders with advanced tools and a fun, interactive environment. Powered by the Ainalyzr token, it offers real-time analysis of Solana-based tokens, gamified trading tools, and a space for users to explore market trends and make data-driven decisions. Ainalyzr merges functionality and entertainment, appealing to both seasoned and novice traders.

AInalyzr

AInalyzr ($AINAL.X) is gaining traction as the community highlights its potential for significant growth. Investors are discussing its "sleeper gem" qualities and anticipating a potential "lift off". The project's mint and association with other cryptocurrencies like Bitcoin and Solana are central to the conversation.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members highlight its strong chart setup, coiling pattern, and potential for a breakout. Discussions revolve around accumulation phases, steady bullish momentum, and the anticipation of a significant upward move. The community also notes growing awareness and potential partnerships, contributing to the bullish sentiment.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the stock price rallies, fueled by momentum in its energy business and speculation around future AI and robotics initiatives. The community is actively debating whether this surge is justified by fundamentals or driven by market manipulation, with some pointing to a potential short squeeze while others highlight concerns about insider selling and product safety. Discussions also include broader market conditions and potential impacts on the EV sector.

The ODP Corp. is a holding company, which engages in the provision of business services and supplies, products, and digital workplace technology solutions. It operates through the following segments: ODP Business Solutions Division, Office Depot Division, and Veyer Division. The ODP Business Solutions Division acts as a B2B distribution solutions provider serving small, medium, and enterprise level companies, including those in the public and education sectors. The Office Depot Division offers retail consumer and small business products and services distributed through a fully integrated omni-channel platform of 869 Office Depot and OfficeMax retail. The Veyer Division consists of supply chain, distribution, procurement, and global sourcing operation, which specializes in B2B and consumer business service delivery, with core competencies in distribution, fulfillment, transportation, global sourcing and purchasing. The company was founded in 1986 and is headquartered in Boca Raton, FL.

ODP Corporation (The)

$ODP is trending due to controversy surrounding an Office Depot refusing to print a poster, sparking outrage and calls for boycotts, drawing comparisons to Bud Light and Cracker Barrel situations.  The community is focused on the potential financial impact and debating the company's business strategy amidst political divides. Investors are also weighing upcoming earnings and recent research reports.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

Pepe is trending as the community discusses potential breakouts and compares it to other meme coins like Doge and Shib. Some users are expressing frustration with price fluctuations, while others remain optimistic about long-term gains and potential rallies. The conversation also includes mentions of potential market manipulation and the broader meme coin sector.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

ATYR is trending as traders anticipate Phase 3 EFZO-FIT data, expected mid-September, focusing on pulmonary sarcoidosis treatment. The community is actively discussing aggressive ask-side put sweeps, high implied volatility, and potential binary gap risk, while also debating the significance of recent analyst ratings and commercial hires. Some traders are weighing defined-risk setups and hedging strategies amid the uncertainty.

Trump For President

The TRUMP.X crypto is trending amid discussions about a potential ETF and its correlation with other cryptos like BTC and ETH. Community members are debating its future value, especially if Trump actively supports or acknowledges the coin, while also commenting on his recent summit with Putin. Political opinions and sentiments toward Trump are heavily influencing the conversation around this speculative asset.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

$KENDU.X is trending due to its strong community and ongoing efforts to build real-world utility, including businesses and events, with community members highlighting its dedication to growth. Despite some market downturns, the community remains highly engaged, actively promoting the brand and expressing excitement for future developments. The community is currently discussing its unique brandcoin model.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Absci Corporation (ABSI) Reports Q2 Loss, Misses Revenue Estimates

ABSCI CORP (ABSI) delivered earnings and revenue surprises of -26.32% and -74.44%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

SAB Biotherapeutics (SABS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Absci Corporation (ABSI) Expected to Beat Earnings Estimates: Should You Buy?

ABSCI CORP (ABSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amgen (AMGN) Beats Q2 Earnings and Revenue Estimates

Amgen (AMGN) delivered earnings and revenue surprises of +14.45% and +3.52%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Beats Revenue Estimates

Syndax (SNDX) delivered earnings and revenue surprises of +17.00% and +30.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains?

Coya Therapeutics, Inc. (COYA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates

FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape

FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape FDA Approval Race: AI-Powered Innovations Reshape the Healthcare Landscape PR Newswire VANCOUVER, BC, Feb. 11, 2025 USA News...

Is AMD Stock a Buy, Sell, or Hold on HSBC’s Double Downgrade?

AMD stock fell after an analyst slashed his price target and rating on the stock due to Nvidia competition and weak AI GPU demand.

Absci Corp. shares gained over 4% in the previous session, drawing the most retail interest among biotech stocks on Stocktwits after the company announced a strategic partnership with AMD, which includes a $20 million investment pledge from the chipmaker.&nbsp;This investment, structured as a private investment in public equity (PIPE), reportedly marks AMD’s entry into life sciences, leveraging its AI chips for drug discovery.The collaboration aims to integrate AMD’s high-performance computing capabilities with Absci’s AI-powered de novo antibody design models.&nbsp;The partnership will be showcased at the upcoming 43rd Annual J.P. Morgan Healthcare Conference on Jan. 15, Absci said.Retail engagement on Stocktwits skyrocketed, with message volume surging by 36,900% on Wednesday.&nbsp;Sentiment on the platform for Absi was 'bullish' heading into Friday even as profit-taking set in, as the company revealed another partnership.&nbsp;<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ABSI_sentiment_and_message_volume_Jan_10_premarket_c443462d4e.png" alt="ABSI sentiment and message volume Jan 10 premarket.png" width="1318" height="324"><figcaption>ABSI sentiment and message volume Jan 10 premarket as of 7:50 am ET | source: Stocktwits</figcaption></figure>Absci and Owkin announced they have teamed up to harness their advanced AI platforms to speed up the discovery and design of new medicines. The partnership will focus on creating treatments for cancer and other conditions like immune disorders and inflammation.&nbsp;<stembedurl>https://stocktwits.com/GeraldK75/message/599519367</stembedurl><stembedurl>https://stocktwits.com/J_The_Legend/message/599520163</stembedurl><stembedurl>https://stocktwits.com/GeraldK75/message/599508901</stembedurl>Adding to Wednesday’s optimism, Cathie Wood’s ARK Investment purchased 608,900 Absci shares, through its ARK Genomic Revolution ETF (ARKG), valued at over $1.9 million as of the last close.&nbsp;AI-driven drug discovery is a space being increasingly targeted by major tech players. Last year, Nvidia&nbsp;<a href="https://stocktwits.com/news-articles/markets/5/top-biotech-stocks-with-highest-retail-chatter-in-2024/cJOEinNRjV">invested</a> $50 million in Recursion Pharmaceuticals for similar initiatives.KeyBanc lowered its price target for Absci to $5 from $6&nbsp;on Wednesday but maintained an ‘Overweight’ rating, citing the broader rebound in healthcare technology stocks following Donald Trump’s election.&nbsp;The brokerage said it sees opportunities in companies with strong balance sheets but warned of risks for those with limited profitability.&nbsp;Absci reported $127.1 million in cash and equivalents as of September 30, 2024, down from $145.2 million the previous quarter.Shares of the company remain down over 22% over the past 12 months.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Close up of scientist hand inoculating an agar plates with bacteria in microbiology lab | Image source: Getty Images

Small-Cap Biotech Absci Draws Heavy Attention On $20M AMD Investment Pledge, Retail's Bullish Despite Pre-Market Dip

The investment reportedly marks AMD’s entry into life sciences, leveraging its AI chips for drug discovery.

Equity

The investment reportedly marks AMD’s entry into life sciences, leveraging its AI chips for drug discovery.


Absci Corp. is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins. It partners with pharma and biotech innovators to create the next generation of protein-based drugs. The company was founded by Sean McClain in 2011 and is headquartered in Vancouver, WA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	-$0.20	--	--	N/A
Q2 '25	-$0.21	-$0.24	-15.07%	MISSED
Q1 '25	-$0.22	-$0.21	6.10%	BEAT
Q4 '24	-$0.22	-$0.25	-11.77%	MISSED
Q3 '24	-$0.19	-$0.24	-23.64%	MISSED

ABSI
Absci Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q3 '25

Historical Earnings

Latest ABSI News

ABSI Absci Corp